LGC
CLB icon

Laurel Grove Capital’s Core Laboratories CLB Stock Holding History

Laurel Grove Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-3,350
Closed -$350K – 104
2015
Q1 		$350K Buy
3,350
+1,100
+49% +$117K 0.19% 84
2014
Q4 		$271K Sell
2,250
-3,450
-61% -$453K 0.15% 84
2014
Q3 		$834K Buy
+5,700
New +$880K 0.45% 61

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WI
WHV Investments San Francisco, California $187M AUM 14.29% 1-Year Est. Return

Laurel Grove Capital's CLB Position: Q2 2015 in Review

Laurel Grove Capital sold out of Core Laboratories (CLB) in Q2 2015, closing a stake of 3,350 shares — an estimated $350K sold.

Laurel Grove Capital first reported a position in CLB in Q3 2014 and held it in 3 quarters. The position peaked at $834K in Q3 2014. 356 funds tracked by Wall St. Rank hold CLB as of Q2 2015.

  • Laurel Grove Capital reported no remaining Core Laboratories position as of Q2 2015 after selling out during the quarter.
  • Laurel Grove Capital sold 3,350 Core Laboratories shares in Q2 2015, an estimated $350K.
  • Laurel Grove Capital first reported a position in Core Laboratories in Q3 2014 and held it in 3 quarters.
  • Laurel Grove Capital's Core Laboratories position peaked at $834K in Q3 2014.
  • 356 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2015.

Based on Laurel Grove Capital's 13F filing for Q2 2015, filed 14 Jul 2015.